As targeting Lck to light DRMs predicates enhanced TCR-mediated IL-2 production (21) and alternations in the association of Lck with accessory molecules within light DRMs supports abnormal T-cell signaling in autoimmune diseases (58), elucidation of the nature of this process on the molecular level represents a topic of academic and clinical interest. Here, LCK is linked to autoimmune disease.